R Dorey1, C Piérard, F Chauveau, V David, D Béracochéa. 1. CNRS, Universités de Bordeaux, Institut de Neurosciences Cognitives et Intégratives d'Aquitaine-INCIA, UMR, Talence, France.
Abstract
The present study was aimed at determining the relative contribution of the dorsal (DH) and ventral (VH) hippocampus in stress-induced memory retrieval impairments. Thus, we studied the temporal involvement of corticosterone and its receptors, i.e. mineralocorticoid (MR) and glucocorticoid (GR) in the DH and VH, in relation with the time-course evolution of stress-induced memory retrieval impairments. In a first experiment, double microdialysis allowed showing on the same animal that an acute stress (electric footshocks) induced an earlier corticosterone rise in the DH (15-60 min post-stress) and then in the VH (90-105 min post-stress). The return to baseline was faster in the DH (105 min) than in the VH (120 min). Memory deficits assessed by delayed alternation occurred at 15-, 60-, and 105-min delays after stress and were closely related to the kinetic of corticosterone rises within the DH and VH. In a second experiment, the GR antagonist RU-38486 and the MR antagonist RU-28318 were administered in the DH or VH 15 min before stress. RU-38486 restored memory at 60 but not at 105 min post-stress delays in the DH, whereas the opposite pattern was observed in the VH. By contrast, RU-28318 had no effect on memory impairments at both the 60- and 105-min post-stress delays, showing that MR receptors are not involved at these delays. However, RU-28318 administered in the DH restored memory when administered at a shorter post-stress delay (15 min). Overall, our data are first to evidence that stress induces a functional switch from the DH to VH via different corticosterone time-course evolutions in these areas and the sequential GR receptors involvement in the DH and then in the VH, as regards the persistence of stress-induced memory retrieval deficits over time.
The present study was aimed at determining the relative contribution of the dorsal (DH) and ventral (VH) hippocampus in stress-induced memory retrieval impairments. Thus, we studied the temporal involvement of corticosterone and its receptors, i.e. mineralocorticoid (MR) and glucocorticoid (GR) in the DH and VH, in relation with the time-course evolution of stress-induced memory retrieval impairments. In a first experiment, double microdialysis allowed showing on the same animal that an acute stress (electric footshocks) induced an earlier corticosterone rise in the DH (15-60 min post-stress) and then in the VH (90-105 min post-stress). The return to baseline was faster in the DH (105 min) than in the VH (120 min). Memory deficits assessed by delayed alternation occurred at 15-, 60-, and 105-min delays after stress and were closely related to the kinetic of corticosterone rises within the DH and VH. In a second experiment, the GR antagonist RU-38486 and the MR antagonist RU-28318 were administered in the DH or VH 15 min before stress. RU-38486 restored memory at 60 but not at 105 min post-stress delays in the DH, whereas the opposite pattern was observed in the VH. By contrast, RU-28318 had no effect on memory impairments at both the 60- and 105-min post-stress delays, showing that MR receptors are not involved at these delays. However, RU-28318 administered in the DH restored memory when administered at a shorter post-stress delay (15 min). Overall, our data are first to evidence that stress induces a functional switch from the DH to VH via different corticosterone time-course evolutions in these areas and the sequential GR receptors involvement in the DH and then in the VH, as regards the persistence of stress-induced memory retrieval deficits over time.
The dorsal (DH) and ventral (VH) regions of the hippocampus (HPC) are anatomically and
functionally distinct areas (Fanselow and Dong, 2010). More
specifically, the DH is mainly connected through differential connections with the
neocortex, whereas VH is mainly connected with the amygdala and hypothalamus (Moser and Moser, 1998; Naber and Witter,
1998; Segal ). On the other
hand, the DH would be primarily involved in cognitive processes sustaining learning and
spatial memory processes, whereas VH would be associated with motivational and emotional
behaviors (Segal ).Glucocorticoids (GCs) primarily act through glucocorticoid receptors (GR) and
mineralocorticoid receptors (MR). Both types of receptors are highly co-localized in
limbic structures and particularly within the HPC (De Kloet ; Van Eekelen ).These two receptor types are, however, differentially distributed in the
brain (Reul and de Kloet, 1985). Thus, MR are highly
expressed in neurons of the hippocampal formation and the lateral septum and moderately
expressed in subnuclei of the amygdala, the hypothalamic paraventricular nucleus, and the
locus coeruleus (Joëls ). These
regions define a circuit that is involved in the cognitive, emotional, and neuroendocrine
processing of stressful events (McGaugh, 2004). GR are
ubiquitously expressed in the brain, but mainly in the HPC, the lateral septum, and the
paraventricular nucleus (Joëls and Baram, 2009). MR
receptors have a high affinity for corticosteroids, so they are mostly occupied even when
circulating corticosteroid levels are low, whereas GR have tenfold lower affinity and
become more occupied as corticosteroid levels increase—for example, after stress
(Joëls ).From a functional point of view, steroids can rapidly modulate neuronal activity through
a non-genomic pathway via an activation of membrane receptors (Borski,
2000; Falkenstein ;
Makara and Haller, 2001; Dallman,
2005; Tasker ; Groc ; Conboy and Sandi,
2010) and synaptic excitatory transmission (Pfaff ; Chaouloff and Groc, 2011).
Steroids also increase the release of excitatory amino acids (Venero
and Borrell, 1999). In addition to rapid membrane mechanisms, corticosteroid
receptors could also translocate to the nucleus, where they act as regulators of gene
transcription (Lu ; Revest ). Therefore, steroid effects on
neuronal function usually require at least 1 h to develop and last hours to days.
In the HPC, MR activation is a prerequisite for maintaining the ongoing information flow,
whereas activation of GR—for example, after stress—causes a delayed
suppression of neuronal excitability and synaptic plasticity (Joëls ; Kim and Diamond,
2002), thus providing ‘negative-feedback regulation' of behavioral
aspects of the stress response (see Joëls and Baram,
2009).From a cognitive point of view, it has been shown that GC receptors modulate spatial and
non-spatial memory (De Quervain ;
Kim and Diamond, 2002; Roozendaal,
2003; Ferguson and Sapolsky, 2007). It has been
proposed that GR receptors would sustain delayed effects on memory via transcriptional
factors (McEwen and Sapolsky, 1995; De
Kloet ; Sapolsky ; Lupien and Lepage, 2001; McGaugh and Roozendaal, 2002; Donley ; Joëls ; Joëls and Baram, 2009), whereas MR
would be primarily involved in the rapid cognitive effects of stress. In particular, it
has been shown that MR mediate the corticosterone-induced impairment of memory retrieval
(Khaksari ). However, the rapid
effects of corticosterone on behavior and cognitive processes remain seldom documented
(Orchinik ; Sandi ; Breuner ; Sajadi ).We previously showed that acute stress induced a rapid (15 min) corticosterone
rise in the DH associated to memory-retrieval deficits (Chauveau
), which specifically implicated MR but not GR receptors
via non-genomic membrane mechanisms (Dorey ). However, as in our previous study, the memory deficit lasted at least
60 min after stress, and because one cannot exclude that stress could activate
simultaneously both the VH and DH, we now intend to determine the relative involvement of
the DH and VH and the GC receptor types in the rapid and delayed effects of stress on
memory retrieval.To these aims, experiment 1 was designed to measure simultaneously in both the
DH and VH the stress-induced time-course evolution of corticosterone rise after acute
stress. In a further step, experiment 2 was designed to determine the involvement of the
GC receptors (MR and/or GR) on memory impairments associated with the stress-induced
time-course evolution of corticosterone rise in the DH and/or VH.
MATERIALS AND METHODS
Experimental Design
Experiment 1 was designed (i) to test the impact of an acute stress on the
time-course evolution of corticosterone rises both in the DH and VH, measured in the
same mouse by microdialysis and (ii) to evaluate the impact of stress on memory
retrieval in independent groups of mice at different delays after stress delivery,
according to data drawn from the microdialysis experiment.Experiment 2 was designed to determine the type of GC receptors involved in
the delayed (15, 60, and 105 min) stress-induced memory impairments. These delays
were chosen according to the time-course evolution of corticosterone levels observed in
the DH and VH after stress. The GR antagonist RU-38486 or the MR antagonist RU-28318
were injected into the DH or VH 15 min before stress delivery and memory was
assessed at either 15-, 60-, or 105-min post-stress delay intervals.
Animals
The subjects were 6-month-old male mice of the C57BL/6 inbred strain obtained from
Charles Rivers (France). At the time of the experiments, mice weighed between 28 and
32 g. They were housed individually with free access to water on a 12-h
light–dark cycle in a temperature-controlled and ventilated room. Tests were
conducted during the light phase of the cycle between 0800 and 1200 hrs. The
number of animals in each group is given in the Results section.
Experiment 1
Surgery
Mice were anesthetized with a ketamine (1 mg/kg body weight)-xylazine
(10 mg/kg body weight) solution and placed on a stereotaxic frame. Two
microdialysis guide-cannulae (for CMA/7 microdialysis probes, CMA Microdialysis,
Sweden) were implanted at the following coordinates from the bregma (Paxinos and Franklin, 2001): for the DH:
AP=−2000 μm, L=±1300 μm, and
V=−1000 μm; for the VH: AP=−3000 μm,
L=±2900 μm, and V=−3000 μm). The
laterality of implantation in the DH and VH was randomized as half of the animals were
implanted in the right side for the DH and left side for the VH, whereas the other
half were implanted in the opposite way.Guide-cannulae were fixed with dental cement and three micro screws attached to the
skull. All operated mice were allowed to recover in the animals room.
Microdialysis
Microdialysis was performed in freely moving animals to measure corticosterone levels
in the DH and VH after acute stress. Indeed, in vivo microdialysis is an
extremely powerful method to study the highly dynamic neurotransmitter responses in
the field of stress physiology and behavior (Linthorst and Reul,
2008; Dorey ).On the day before the experiment, microdialysis probes (CMA/7, membrane length
1 mm; CMA Microdialysis, Sweden) were inserted through the guide-cannulae so
that their membranes were lowered 1 mm below guide-cannulae into the DH or VH.
Probes were continuously perfused with sterile, filtered Dulbecco's solution
(mock CSF) at a rate of 0.1 μl/min. Equilibration of extracellular
concentrations lasted 12 h, i.e., in the night before the test day. After the
equilibration phase, baseline dialysates (15-min samples) were collected in the
morning with a flow rate of 1 μl/min during 2 h. Then, the acute
stress was applied using a footshocks delivery system located in the dialysis cage.
The acute stress was constituted by three successive unavoidable electric footshocks
(0.9 mA; 10 ms) in keeping with our previous studies (Chauveau ; Dorey
). The dialysates were collected during 3 additional
hours after stress (flow rate: 1 μl/min; sampling delay: 15 min).
Samples were stored at −80 °C before analysis. Free corticosterone
levels measured in the dialysates were expressed as the percentage of the averaged
baseline values.At the end of the microdialysis experiment, mice were anesthetized and then
transcardially perfused in the left ventricle with saline solution (NaCl 0.9%)
followed by formaldehyde (4%). Brains were then post-fixed in a 4%
formaldehyde solution for 10 days, and then in a saccharose-formaldehyde solution
(30–40% v/v) for 2 days. All the brains were coronally sectioned
(50 μm thickness). A cresyl violet stain was used to check the exactness of
the microdialysis probes implantation.
Intra-hippocampal corticosterone assay
An Enzyme Immunoassay commercial kit (Correlate-EIA, Assay Designs, Ann Arbor, USA)
was used to measure HPC corticosterone concentrations in the microdialysates. The
sensitivity of the assay was 18.6 pg/ml. Therefore, baseline sample
concentration was more than 10-fold above the sensitivity threshold.
Plasma corticosterone assay
Independent groups of mice were used (29 mice as a whole). Mice were placed in the
footshocks delivery system located in the microdialysis cage, for at least 1 h
before being administered with the electric footschocks used in the microdialysis
experiment. After stress, they remained in the microdialysis cage and were decapitated
to collect trunk blood after either 15 min (N=4), 30 min
(N=4), 60 min (N=4), 90 min
(N=4), 105 min (N=4), or 120 min
(N=4) post-stress delays. Control animals were submitted to the same
experimental conditions but did not receive footshocks (N=5). They
were killed 1 h after being placed in the shock delivery system included in the
microdialysis cage. Thus, these animals constitute a ‘time 0' control
group. After centrifugation at 3000 r.p.m. for 10 min, the supernatant
was stored at −80 °C until ELISA assay (Correlate-EIA, Assay Designs,
Ann Arbor, USA).
Acute stress delivery
The same acute stress (0.9 mA; 10 ms) was applied for behavioral
experiments. Stress was delivered in a room different from the one used for behavioral
testing. Mice remained for 1 min in a stress delivery cage. Non-stressed mice
were placed in the cage in the same conditions except that they did not receive
footshocks.
Behavioral task: delayed alternation procedure
The procedure and methods have been extensively described in a previous study (see
Dorey for detailed information).
Memory was evaluated by delayed alternation rate in a T-maze used as an index of
memory performance (Figure 1). Testing was conducted
between 0800 and 1200 hrs, in order to minimize the circadian variations of
corticosterone.
Figure 1
Memory testing procedure: during a session, animals were first submitted to an
acquisition phase in which they were forced to enter twice the same arm of the maze (two
forced trials). Then, after a 24-h delay interval, they were submitted to the test phase
in which they can freely enter either in the right or in the left arm of the maze. An
alternation was scored when the mouse entered the arm opposite to the one visited in the
acquisition phase. Treatments (stress and antagonists injections in the DH and VH) were
delivered before the test phase, according to the experimental schedule described in the
Materials and Methods section.
In the acquisition phase, the subjects were forced to enter twice the same arm of the
maze. The two forced trials were separated by a 30-s interval. The acquisition phase
was followed by a test phase implemented 24 h later. During the test trial,
animals remained 30 s in the start box. The door was then opened, and animals
were free to enter into one of the arms of the maze. The correct choice is to enter
the arm opposite to that entered the day before. In all the experiments, animals were
automatically confined for 30 s in the chosen arm by the closing of a slide
door. Thus, this confinement period was imposed on the animals. The closing of the
slide door was automatically triggered by the crossing of photoelectric cells placed
at the middle of the arm, requiring that the subject completely entered the chosen
arm. Thus, the closing of the door determines the criterion to score the choice of the
mouse. The mouse remained 30 s into the chosen arm before being replaced for
30 s in the start-box for a subsequent free choice trial. This short-term trial
was aimed at determining whether the intrinsic psychomotor ability and motivation of
mice to alternate were spared by the treatments, so that any deficits observed at the
previous 24 h test trial cannot be ascribed to either psychomotor or
motivational impairments.Mice were submitted to two forced trials sessions in the same experimental
conditions. The blocked arm of the second session was opposite to the one blocked in
the first session. Each session was separated by a 1-week period. Thus, each mouse
served as its own control to avoid place preference bias in the alternation
performance during the test sessions.The test sessions took place 15, 60, or 105 min after the acute stress
administration.
Experiment 2
Mice were anesthetized with a ketamine (1 mg/kg body weigh)-xylazine
(10 mg/kg body weight) solution. Stereotaxic coordinates are referenced in
μm from the bregma (Paxinos and Franklin, 2001). For
pharmacological administration in the DH, two stainless-steel guide cannulae (26
guage, 8 mm length) were implanted bilaterally 1 mm above the surface of
the DH (AP=−2000 μm; L=±1300 μm; and
V=−1000 μm). For administration in the VH, two stainless-steel
guide-cannulae (26 guage, 8 mm length) were implanted bilaterally at the
following coordinates (AP=−3000 μm;
L=±2900 μm; and V=−3000 μm). Guide-cannulae
were fixed in place with dental cement and three micro screws attached to the skull.
All operated mice were allowed to recover in the animal room for at least 7 days
before behavioral experiments.Antagonists were injected through two 32-guage stainless-steel cannulae (9 mm
length) attached to a microsyringe with polyethylene catheter tubing. The cannulae
were inserted into the guide-cannulae. The syringes were placed in a constant flow
rate pump (0.4 μl/min). Corticosterone receptors antagonists (RU-38486
and RU-28318; Tocris, USA) at the concentration of 20 mg/ml or vehicle
(mock CSF additioned with a small amount of absolute ethanol) were bilaterally
injected 15 min before stress delivery in either the DH or VH. The antagonists
were injected in a volume of 0.40 μl per side (0.05 μl/min
during 8 min). The choice of these doses was already validated according to the
behavioral data described in a previous paper (Dorey ). Moreover, we already showed that these MR and GR
antagonists at the very same doses have no effects on memory in the same task in
non-stressed mice (Dorey ).Experimental animals (i.e. animals receiving the MR or GR antagonists injections)
were compared with animals which were implanted with cannulae and received the vehicle
solution only, either in stress or non-stress conditions (stressed+vehicle or
non-stressed+vehicle groups, respectively).
Behavioral schedule
The behavioral procedure was similar to that of Experiment 1. Behavioral testing
occurred 15 min after stress. Independent groups of mice were tested for three
post-stress delays according to the results obtained in Experiment 1 i.e. 15, 60, and
105 min. Mice were submitted to two forced trials sessions with the same
antagonist dose and experimental conditions. The blocked arm of the second session was
opposite to the one blocked during the first session. Each session was separated by a
wash-out period of 1 week. Thus, each mouse served as its own control to avoid
place preference biases. After behavioral testing, mice were killed, and their brains
were removed and coronally sectioned (50 μm thickness). A cresyl violet
stain was used to verify the exact probe location in the DH and VH.
Statistical analysis
Statistical analyses were performed using the Statview 5.0 software. In the behavioral
experiments, data drawn from the two test sessions were averaged and expressed as
means±SEM. The data were analyzed using one-way or two-ways factorial analyses of
variance (ANOVA) followed, when adequate, by post-hoc comparisons
(Bonferroni/Dunnett test). Comparisons of retrieval performances with chance level
were calculated with one sample Student's t-test (with hypothesized
mean=chance level of 50%). Microdialysis data were analyzed using one- or
two-ways repeated-measure ANOVA as appropriate, followed when adequate by post-hoc
testing (Bonferroni/Dunnett test).One animal out of 10 in Experiment 1 and 5 animals out of 70 in Experiment 2 were
excluded a posteriori from statistical analyses because of inaccurate
implantation of cannulae for microdialysis or pharmacological injections.
RESULTS
1st Experiment: Effects of Acute Stress on Hippocampal and Plasma Corticosterone
Concentrations and Delayed Alternation rates.
Stress-induced intra-HPC corticosterone rise
The absolute concentrations of corticosterone in baseline condition are not
significantly different between the DH and VH (251.4±14.1 ng/l vs
275.0±14.5 ng/l respectively; F(1,18)=1.35;
p=0.26, NS). Figure 2a represents
corticosterone levels in the HPC areas, DH (n=10) and VH
(n=10), in which results are expressed in relative concentrations
(i.e. as percentage of variation of baseline). Two-way repeated-measures ANOVA
performed on corticosterone kinetic evidenced a significant interaction between the
HPC areas and time (F(14,252)=2.93; p≤0.0004). Thus, the
time-course evolutions of corticosterone in the DH and VH are overall significantly
different.
Figure 2
(a) Time-course evolutions of stress-induced corticosterone in the dorsal (DH) and
ventral (VH) hippocampus measured by microdialysis in the same animal. In the DH, the
corticosterone rise is significant at the 15-min post-stress delay. The maximum
corticosterone concentration occurred at 60 min post-stress delay with a return
to baseline level 105 min after stress delivery. In VH, a significant
corticosterone rise is observed at the 90-min post-stress delay, and the maximum
corticosterone concentration is measured 105 min after stress delivery with a
return to baseline at 120 min. Results are expressed in relative concentrations.
Comparisons with baseline: for the DH: *p<0.05;
**p<0.01; ***p<0.001; for the VH:
+p<0.05; +++p<0.001;
between group comparisons: o- p<0.05; (b) Plasma corticosterone
concentrations (ng/ml) at different post-stress delays were measured in independent
groups of mice. Plasma corticosterone concentrations are significantly increased from 15
to 105 min after stress with a maximum corticosterone concentration at the 60-min
post-stress delay. *p<0.05; **p<0.01 as compared
with the non-stressed animals. (c): Effect of stress on delayed alternation performance
at several post-stress delays. Stress significantly decreases alternation rates from 15
to 105 min after delivery, whereas no deficit was observed at the 120-min
post-stress delay. Comparison with non-stressed group: *p<0.05;
**p<0.01.
Intergroup comparisons showed that corticosterone levels in the DH and VH
significantly differed for 60 min (197.4±24.7 vs 110.9±7.5,
respectively; p<0.05) and 105 min (103.0±10.5 vs
165.0±19.2%, respectively; p<0.05). Thus, our data show that
rise in corticosterone in the DH appears to be earlier than in the VH.
Dorsal Hippocampus
As compared with the last pre-stress sample (97.1±6.7%
‘time=0'), stress induced a progressive and significant increase in
corticosterone levels from 15 min (137.6±20.2%
t=2.30; p≤0.05) to 90 min (139.1±24.1%
t=2.32; p≤0.05). Furthermore, the highest difference was
observed 60 min after stress administration (197.4±24.7;
t=3.57; p≤0.01).
Ventral Hippocampus
As compared with the last pre-stress sample (97.3±4.9%
‘time=0'), stress induced a significant increase in corticosterone
levels for 90 min (129.4.±19.6% t=2.49;
p≤0.05) and 105 min (165.0±19.2%
t=3.82; p≤0.01). Furthermore, the highest difference was
observed 105 min after stress administration.
Stress-induced plasma corticosterone rise
ANOVA showed a significant global between-groups difference (F(6,22)=8.83;
p<0.001; see Figure 2b). More specifically,
stress induced a significant increase of plasma corticosterone level at the
post-stress delays of 15 min (53.8±2.4 ng/ml; p<0.05),
30 min (66.6±7.0 ng/ml; p<0.05), 60 min
(92.2±19.7 ng/ml; p<0.01), 90 min
(78.5±7.6 ng/ml; p<0.01), and at 105 min
(50.3±0.65 ng/ml; p<0.05) as compared with non-stressed
animals (30.3±3.6 ng/ml). By contrast, the increase in
corticosterone at the 120 min (46.2±7.6 ng/ml; NS) post-stress delay
was not significantly different from non-stressed mice.
Effects of acute stress delivered 15, 60, 105, and 120 min before memory
testing on alternation performance
Data are represented in Figure 2c. The data revealed a
significant between-group difference (F(4,90)=6.2; p=0.017).
More precisely, non-stressed mice (n=19) exhibited alternation rates
(79.1±9.8%) significantly above those observed in stressed ones tested
15 min after stress (n=20; 44.4±8.9;%
p<0.05), 60 min after stress (n=18; 46.2±
13.3; p<0.05), and 105 min after stress (n=20;
35.1±10.7% p<0.01). By contrast, stressed mice tested
120 min after stress exhibit performance similar to those of non-stressed ones
(n=18; 79.1±7.6% NS). Only the non-stressed and
stressed 120 min groups differed significantly from chance level (50%
p<0.01 in each comparison.)All the groups exhibited similar short-term alternation rates evaluated 30 s
after the delayed test session (92.0±5.5%, 85.6±6.4,
90.7±6.8, 92.1±4.9, and 87.4±5.8 for the non-stressed and
stressed groups at 15, 60, 105, and 120 min, respectively;
F<1.0).
Second Experiment: Effects of Intra-DH or VH Antagonists Injections on Delayed
Alternation Rates
Effects of MR and GR antagonists injections in DH at 15 min post-stress
delay
Data are presented in Figure 3. The data revealed a
significant between-group difference (F(3,68)=6.3; p<0.01). More
precisely, the non-stressed+vehicle group exhibited significant higher
alternation rates (n=19; 78.8±10.0%) as compared with
the performance of the stressed+vehicle group (n=18;
44.7±8.8% p<0.05) and as compared with that of the stressed
animals receiving the GR antagonist (n=19; 43.5±8.8%
p<0.01). By contrast, they did not differe from the stressed animals
receiving the MR antagonist (n=16; 84.1±5.9% NS). Only
the non-stressed+vehicle and stressed+MR antagonist groups differed
significantly from chance level (50% p<0.01 and 0.001,
respectively).
Figure 3
Effect of GR antagonist (RU-38486 or mifepristone) and MR antagonist (RU-28318 or
oxprenoate) injections into the DH on delayed alternation performance in stressed mice
tested 15 min after stress delivery. The doses of antagonists were selected
according to a previous study (Dorey ). The antagonists were bilaterally injected 15 min before stress
and 30 min before the test session. Control groups received the vehicle solution.
As can be observed, the MR but not GR antagonist reversed the stress-induced decrease of
alternation rates. Comparisons with non-stressed vehicles;
+p<0.05; ++p<0.01;
Comparisons with chance level (50%): **p<0.01;
***p<0.001.
All groups exhibited similar short-term alternation rates evaluated 30 s after
the 24 h delayed test session (82.0±5.3%,
79.0±4.7%, 85.2±7.1, and 84.3±6.8%, respectively,
for the non-stressed+vehicle, stressed+vehicle, stressed+MR antagonist,
and stressed+GR antagonist groups, respectively; NS in all comparisons).
Effects of MR and GR Antagonists Injections in the DH and VH at 60 min
Post-stress Delay
Dorsal hippocampus
Data are presented in Figure 4a. The data revealed a
significant between-group difference (F(3,72)=7.1; p<0.01). More
precisely, the non-stressed+vehicle group exhibited significant higher
alternation rates (n=18; 77.9±9.6%) as compared with the
performance of stressed+vehicle group (n=18;
45.9±11.0% p<0.05) and as compared with the stressed animals
receiving the MR antagonist (n=20; 39.2±11.0%
p<0.05). By contrast, they did not differ from the stressed animals
receiving the GR antagonist (n=20; 73.2±9.6% NS). Only
the non-stressed+vehicle and stressed+GR antagonist groups differed
significantly as compared with chance level (50% p<0.01 and 0.05,
respectively).
Figure 4
Effects of GR antagonist (RU-38486 or mifepristone) and MR antagonist (RU-28318 or
oxprenoate) injections into the DH or VH on delayed alternation rates at 60 and
105 min post-stress delays. In all experiments described in Figure 4a-d, both MR and GR antagonists were bilaterally injected at the
dose of 20 mg/ml 15 min before stress and 30 min before
behavioral testing. (a) Injections into the DH, test at 60 min post-stress:
control groups' animals received the vehicle solution. The administration of GR
but not of MR antagonist reversed the stress-induced alternation deficit as compared to
vehicle. (b) Injections into the VH, test at 60 min post-stress: the same injections and
doses of MR and GR antagonists did not reverse the stress-induced memory impairments as
compared with vehicle. (c) Injections into the DH, test at 105 min post-stress:
both MR and GR antagonists did not reverse the stress-induced memory impairments as
compared with vehicles; (d) injections into the VH, test at 105 min post-stress.
The administration of GR but not of MR antagonist reversed the stress-induced
alternation deficit as compared with vehicle. (a–d) Comparisons with non-stressed
vehicle: +p<0.05; ++p<0.01;
comparisons with chance level (50%): *p<0.05;
**p<0.01.
All groups exhibited similar short-term alternation rates evaluated 30 s after
the 24 h delayed test session (82.5±6.3%,
81.0.0±8.5%, 77.5±10.8%, and 86.7±7.3%,
respectively, for the non-stressed+vehicle, stressed+vehicle,
stressed+MR antagonist, and stressed+GR antagonist groups, respectively; NS
in all comparisons).
Ventral hippocampus
Data are presented in Figure 4b. The data show that the
injection of either the MR or GR antagonist was unable to restore memory performance
in stressed animals.The data revealed a significant between-group difference (F(3,66)=5.7;
p<0.001). More precisely, the non-stressed+vehicle group exhibited
significant higher alternation rates (n=17; 85.3±5.6%)
as compared with the performance of the stressed+vehicle group
(n=15; 46.6±9.0% p<0.01) and as compared
with the stressed animals receiving the MR antagonist (n=17;
55.8±8.4% p<0.05) or the GR antagonist
(n=21; 52.3±5.4% p<0.01). Only the
non-stressed+vehicle group differed significantly as compared with chance level
(50% p<0.01).All groups exhibited similar short-term alternation rates evaluated 30 s after
the 24 h delayed test session (90.8±4.3%,
87.6.0±8.1%, 83.2±6.9%, and 89.7±5.9%,
respectively, for the non-stressed+vehicle, stressed+vehicle,
stressed+MR antagonist, and stressed+GR antagonist groups, respectively; NS
in all comparisons).
Effects of MR and GR Antagonists Injections in the DH and VH at 105 min
Post-stress Delay
Dorsal Hippocampus
Data are presented in Figure 4c. The data revealed a
significant between-group difference (F(3,72)=6.2; p<0.05). More
precisely, the non-stressed+vehicle group exhibited significant higher
alternation rates (n=20; 79.0±10.2%) as compared with
the performance of the stressed+vehicle group (n=19;
35.0±10.8% p<0.01) and as compared with the stressed animals
receiving the MR antagonist (n=18; 46.5±12.7%
p<0.05) and also as compared with the stressed animals receiving the GR
antagonist (n=18; 49.7±10.3% p<0.05). Only
the non-stressed+vehicle group differed significantly as compared with chance
level (50% p<0.01).All groups exhibited similar short-term alternation rates evaluated 30 s after
the 24 h delayed test session (91.5±6.2%,
79.6±5.6%, 76.6±9.7%, and 87.3±6.1%,
respectively, for the non-stressed+vehicle, stressed+vehicle,
stressed+MR antagonist, and stressed+GR antagonist groups, respectively; NS
in all comparisons).
Ventral Hippocampus
Data are presented in Figure 4d. The data revealed a
significant between-group difference (F(3,72)= 9.2; p<0.01). More
precisely, the non-stressed+vehicle group exhibited significant higher
alternation rates (n=19; 77.1±8.3%) as compared with the
performance of the stressed+vehicle group (n=20;
40.8±6.8% p<0.01) and as compared with the stressed animals
receiving the MR antagonist (n=18; 39.1±11.8%
p<0.05) but not as compared with the stressed animals receiving the GR
antagonist (n=18; 72.3±10.9% NS). Only the
non-stressed+vehicle group and the stressed+GR antagonist group differed
significantly as compared with chance level (50% p<0.01 and
p<0.05).All the four groups exhibited similar short-term alternation rates evaluated
30 s after the 24 h delayed test session (F(3,73)<1.0; NS).
Histological Analyses
Figures 5 and 6 show the
anterograde extent and the localization of the cannulae tips in the DH and VH of mice
submitted either to the microdialysis (Figure 5) or to the
pharmacological (Figure 6) experiments. Gray zones: main
implantation sites; black hashed areas: antero-retrograde extent of the cannulae tips
implantation.
Figure 5
Representative localization of the microdialysis probes into the dorsal and ventral
hippocampus in mice of Experiment 1. (a and b) Reconstruction of the antero-posterior
extent of probe locations (gray area: main sites; hashed areas: antero-posterior extent
from the main site). Stereotaxic rostro-caudal coordinates are expressed in mm from
bregma. Photomicrographs illustrate the location of the microdialysis probes in the
dorsal and ventral hippocampus.
Figure 6
Representative localization of the cannulae into the dorsal and ventral hippocampus in
mice of Experiment 2. (a and b) Reconstruction of the antero-posterior extent of the
sites (gray area: main sites; hashed areas: antero-posterior extent from the main
sites). Stereotaxic rostro-caudal coordinates are expressed in mm from bregma.
Photomicrographs illustrate the location of the cannulae in the dorsal and ventral
hippocampus.
DISCUSSION
The main findings of the study are summarized in Figure
7.
Figure 7
Synoptic representation of the main findings of the study. This figure points out a
triple dissociation as regards the time-course involvement of the hippocampus regions,
corticosterone rises and glucocorticoid receptor types in relation with memory retrieval
impairments after acute stress.
In the first experiment, we evidenced that an acute stress (electric footshocks) induced
in the DH then in the VH a corticosterone rise measured by microdialysis. Indeed, we
showed that the maximum corticosterone concentration in VH occurred 45 min later
(105 min post-stress) as compared with the DH (60 min post-stress). On the
other hand, we also observed a concomitant memory retrieval impairment in a non-rewarded
delayed alternation task. Indeed, we found that stress-induced memory deficits occurred
between 15 and 105 min, but were no longer observed at the 120-min post-stress
delay. Thus, one of the main results of the study is that, at least up to the 60-min
post-stress delay interval, the memory deficit does not depend on corticosterone rise into
the VH. In the second experiment, we showed that the stress-induced memory deficit
observed 15 min after stress was antagonized by injections of MR but not of GR
antagonists (RU-28318 and RU-38486, respectively) in the DH. By contrast, with a 60-min
post-stress delay, the GR but not the MR antagonist alleviated the memory impairment.
However, both antagonists injected into the DH failed to restore memory performance at the
105-min post-stress delay. In addition, injections of the GR but not the MR antagonist
into the VH blocked the stress-induced memory impairment observed at the 105-min
post-stress delay.From these data, two main questions arise: (i) what is the relative contribution of the
time-dependent regional involvement of the DH and VH in the stress-induced memory
deficits? (ii) What are the mechanisms underlying the sequential involvement of MR and GR
within the HPC?As regards the first issue, behavioral results obtained in the first experiment show that
the time-course evolution of the memory impairments is concomitant with the stress-induced
corticosterone rise within the DH and VH. Indeed, the findings drawn from microdialysis
are congruent with our prvious studies showing that memory retrieval impairments are
associated to the DH corticosterone rise 15 but not 120 min after acute stress
delivery (Chauveau ; Tronche ; Dorey ). Surprisingly, however, data of the present study show that
the stress-induced memory deficit observed from 15 to 60 min post-stress delays
does not depend on the VH as corticosterone concentrations in the VH are not different
from baseline for this time-window. By contrast, the memory deficit observed at the
105-min post-stress delay seems to depend on the maximum corticosterone level observed in
the VH, insofar as corticosterone concentrations in the DH are not different from baseline
at this delay. Thus, the different time-course evolutions of corticosterone in the DH and
VH could reflect a sequential involvement of both the HPC regions in the observed
time-dependent stress-induced memory deficits. Such a view is also strengthened by the
observations that GR antagonist administered in the DH is efficient at the 60-min
post-stress delay, whereas inefficient when administered in the VH at the same delay. On
the contrary, the GR antagonist administered in the VH is efficient at the 105-min
post-stress delay, whereas being without effect when administered in the DH at the same
delay.Finally, from a functional point of view, our present data point out a temporal and
spatial dissociation on stress-induced corticosterone rise and retrieval memory
impairments.It remains, however, to understand the mechanisms sustaining the emergence of the
different time-course evolutions of corticosterone in the DH and VH after stress. Previous
data from our team already evidenced the peripheral origin of corticosterone in the DH
after stress. Indeed, we showed that systemic administration of metyrapone (an inhibitor
of corticosterone synthesis) blocked the stress-induced rise of corticosterone in the DH
(Chauveau ) and that mice deprived of
corticosterone-binding globuline (CBG−/− KO mice)
did not show any stress-induced corticosterone rise in the DH (Minni
). In the present study, plasma and HPC corticosterone
were measured in independent groups to avoid blood sampling stress, which could induce
biases on HPC corticosterone quantification. We found that the maximum plasma
corticosterone value occurring at 60 min after stress is in phase with the one
observed in the DH, but not with the one observed in the VH (105 min post-stress).
Given that, we could formulate the hypothesis of a diffusion of corticosterone from the DH
to VH via a mechanism remaining to be determined. For this purpose, we intend to lesion or
inactivate the DH to investigate its role in the delayed corticosterone rise within the VH
after stress.From a functional point of view, it has been proposed that an acute stress would induce a
disconnection between the DH and VH and so far could spare or even increase the functional
activity of the VH and its main brain targets involved in emotional processes (amygdala
and hypothalamus) (Segal ). Our data
are in agreement with this hypothesis, as the maximum corticosterone concentrations
emerged at different post-stress delays in the DH and VH. This suggests a different
time-dependent involvement of both the HPC regions in the stress-induced memory deficits.
According to our data, however, memory functions sustained by the DH are first affected by
the acute stress. Indeed, in the present study, delayed alternation deficits are related
to the earlier stress-induced corticosterone rise within the DH, then in the VH. This
result is in agreement with previous studies from our group showing that an acute stress
delivered 15 min before testing produced memory retrieval impairments in a serial
discrimination task. Indeed, we found that the deficit was observed specifically for the
information sustained by the DH, whereas the information sustained by the BLA-frontal
cortex pathway (heavily connected with the VH) was unaffected (Chauveau , 2009, 2010). Furthermore, the presently observed late involvement of the
VH following acute stress is in agreement with relevant studies indicating that the DH
would be much more involved in processing cognitive information, whereas the VH has a key
role in late consolidation of emotional memory and/or anterograde memory processes
(Segal ; Fanselow and Dong, 2010).Even though speculative, we suggest that the late corticosterone rise into the VH could
have a major role on anterograde memory processes and more particularly in the
consolidation of emotional and/or traumatic memory. Indeed, according to our data, one
can hypothesize that the delayed VH activation via GR receptors could be of importance for
the establishment of long-term memory or even that excessive VH activation contributes to
the development of PTSD. Thus, GR antagonists could be a relevant pharmacological
perspective to avoid consolidation or reconsolidation of traumatic events (see Bonne ). So far, in further studies using
animal models of PTSD, we intend to test such drugs in the VH-dependent emotional memory
tasks, i.e. fear conditioning (McEown and Treit, 2009).As regards the second issue, i.e. the mechanisms underlying the sequential involvement of
MR and GR within the HPC, we show that the rapid (15 min) deleterious effects of
stress on memory involved first the MR but not GR receptors in the DH. This result
confirms our previous finding (Dorey ).
In addition, lengthening the post-stress delay from 15 to 60 min involves GR but no
longer MR in so far as only the GR antagonist is efficient to suppress memory impairments.
The lack of memory effects of the MR antagonist at the 60- and 105-min delays cannot be
explained by the fact that the MR antagonist is no longer bound to their receptors.
Indeed, Kim already reported that the
in vivo MR receptor occupancy by RU 28318 was still observed in the rat HPC up
to 2 h after systemic injection.The sequential activation of MR then of GR is in agreement with the view that the rapid
stress response involves first MR (Dorey ) and excitatory neurotransmitter receptors trafficking through GC action
(Groc ; Chaouloff
and Groc 2011) which contribute to the rapid effect of GCs on memory.
GC–glutamatergic interactions have been proposed to explain many of the diverse
actions of GCs on cognition (Conboy and Sandi, 2010;
Sandi, 2011). Furthermore, it has been suggested that
NMDA receptors would be at the interface between cognition and emotion in both the
hippocampal zones (Barkus ).For longer delays, GCs act via a classic genomic action sustained by GR (Joëls, 2008). Moreover, given the high and low affinity of MR
and GR for GCs, respectively, the sequential activation of these receptors could depend on
the hormone concentration at the time of memory testing after stress. However,
electrophysiological data, indicating that stress can also activate simultaneously GR and
MR in different parts of the HPC, have challenged the widely accepted model, which
suggests a time- and dose-dependent effect of steroid hormones on cellular functions in
the HPC. Indeed, as shown by relevant studies on the interaction between LTP and LTD
regulation, corticosteroid modulation of synaptic plasticity in the HPC is a complex
process involving differential activation of MR and GR within the DH and VH (see in
Segal ; Maggio
and Segal, 2012). Nevertheless, our present data agreed overall with the view
developed by Maggio and Segal (2012) suggesting that
steroid hormones act as molecular switches: by changing the strength of synaptic
connectivity in the HPC following stress, they regulate the routes by which the HPC is
functionally linked to the rest of the brain. Indeed, our present data show that along
with synaptic and molecular mechanisms induced by stress, the different time-course
evolutions of corticosterone rises after stress in the DH and VH contribute to the
functional switch from the DH to the VH. Indeed, MR are first involved at the 15-min
post-stress delay when corticosterone concentration is low in the DH, whereas GR are
activated when corticosterone concentration is higher i.e. at 60 min post-stress
delay first in the DH and then at 105 min post-stress delay in the VH.In conclusion, our study using a dynamic approach of the time-course evolution of
corticosterone levels evidenced that stress impairs HPC -dependent memory retrieval via a
mechanism dependent on post-stress delays (from 15 to 105 min), areas (DH
vs VH), and of GC receptor types (MR vs GR). Such a triple
dissociation emphasizes the complexity of the stress–memory interaction,
particularly as regards the relationships between the DH and VH.
Authors: Christopher Barkus; Stephen B McHugh; Rolf Sprengel; Peter H Seeburg; J Nicholas P Rawlins; David M Bannerman Journal: Eur J Pharmacol Date: 2009-10-15 Impact factor: 4.432
Authors: J-M Revest; N Kaouane; M Mondin; A Le Roux; F Rougé-Pont; M Vallée; J Barik; F Tronche; A Desmedt; P V Piazza Journal: Mol Psychiatry Date: 2010-04-06 Impact factor: 15.992
Authors: Jonathan Cedernaes; Frida H Rångtell; Emil K Axelsson; Adine Yeganeh; Heike Vogel; Jan-Erik Broman; Suzanne L Dickson; Helgi B Schiöth; Christian Benedict Journal: Sleep Date: 2015-12-01 Impact factor: 5.849
Authors: Fayaz Seifuddin; Gary Wand; Olivia Cox; Mehdi Pirooznia; Laura Moody; Xiaoju Yang; Jonathan Tai; Gretha Boersma; Kellie Tamashiro; Peter Zandi; Richard Lee Journal: Epigenetics Date: 2017-05-30 Impact factor: 4.528
Authors: Thomas D Prévôt; François Gastambide; Cécile Viollet; Nadia Henkous; Guillaume Martel; Jacques Epelbaum; Daniel Béracochéa; Jean-Louis Guillou Journal: Neuropsychopharmacology Date: 2016-12-16 Impact factor: 7.853
Authors: G Dominguez; N Henkous; C Pierard; C Belzung; N Mons; Daniel Beracochea Journal: Cogn Affect Behav Neurosci Date: 2018-08 Impact factor: 3.282